Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2005
06/22/2005EP0812917B1 Cold-inducible promoter sequences
06/22/2005EP0791066B1 Dna molecules that code for enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing said molecules
06/22/2005EP0758397B1 Recombinant poxviruses with foreign polynucleotides in essential regions
06/22/2005CN1630731A Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals
06/22/2005CN1630730A Methods for detecting and treating the early onset of aging-related conditions
06/22/2005CN1630729A Method for the recombination of genetic elements
06/22/2005CN1630728A Buffer solution for electroporation and a method comprising the use of the same
06/22/2005CN1630727A Nucleic acid for a cloning vector
06/22/2005CN1630726A Beta-lactamase/anminoglycosides modifying enzyme genes, their fusion gene and the expression products, the composition thereof, and their uses in medicine and environmental protection
06/22/2005CN1630725A Ethylene-responsive transcription coactivators in plant
06/22/2005CN1630724A Compositions and methods for inhibiting expression of a target gene
06/22/2005CN1630723A Genetic transformation method for tree
06/22/2005CN1630722A Adapter-directed display systems
06/22/2005CN1630721A Factor VII polypeptides for preventing formation of inhibitors in subjects with haemophilia
06/22/2005CN1630720A Bifunctional fusion proteins with glucocerebrosidase activity
06/22/2005CN1630719A Phytase variants
06/22/2005CN1630718A Improved isoprenoid production
06/22/2005CN1630714A Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression
06/22/2005CN1630713A Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease
06/22/2005CN1630712A Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
06/22/2005CN1630708A Osteoclast-associated receptor
06/22/2005CN1630666A Factor VIII2 C2 domain variants
06/22/2005CN1630665A Anti-A beta antibodies and their use
06/22/2005CN1630664A Caspase-8 binding protein, its preparation and use
06/22/2005CN1630663A Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses
06/22/2005CN1630662A Rabbit hemorrhagic disease vaccine and antigens
06/22/2005CN1630538A Stimulation of vascularization with VEGF-B
06/22/2005CN1630535A Inhibition of STAT-1
06/22/2005CN1630529A B-cell lymphoma specific antigen for use in diagnosis and treatment of B-cell malignancies
06/22/2005CN1630518A Methods of treating and preventing bone loss
06/22/2005CN1630516A Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents
06/22/2005CN1630494A Ophthalmic drug delivery device
06/22/2005CN1630112A GaN-base III-V group nitride light emitting diode and method for manufacturing same
06/22/2005CN1629310A Method of screening peroxisome proliferator-activated receptor antagon and agonist
06/22/2005CN1629304A Chinese Han nationality vascular endothelial growth factor gene recombination, expression, purification and medical uses thereof
06/22/2005CN1629297A Recombinant nucleic acid sequence and method for detecting gene toxicity, mutagenicity and dynamics of gene toxicity for the samples
06/22/2005CN1629296A Recombinant vaccine using flavivirus as vector
06/22/2005CN1629295A Citric acid synthesized enzyme gene and use thereof
06/22/2005CN1629294A Carotenoids related enzyme gene, recombinant yeast vector, transgenic method and transgenic yeast
06/22/2005CN1629293A A rice blast resistance gene, its encoded protein and use thereof
06/22/2005CN1629292A Susceptibility gene closely related to schizophrenia
06/22/2005CN1629291A A shrimp gene Intlp and polypeptides coded thereby
06/22/2005CN1629290A A shrimp gene PIAV and polypeptides coded thereby
06/22/2005CN1629289A Susceptibility gene closely related to schizophrenia
06/22/2005CN1629288A Recombinant Baculovirus for expressing CTB and human insulin fusion protein and use thereof
06/22/2005CN1629287A Method for establishing non-random Ribozyme library and non-random DNAzyme library
06/22/2005CN1629286A 猪单胺氧化酶a蛋白编码序列 Pig a monoamine oxidase protein coding sequence
06/22/2005CN1629285A Natural killer cell for transgenic expression cell chemotactic factors
06/22/2005CN1629203A Preparation of temperature-sensitive chitosan-graft-NIPAAm/VL copolymer transgenic carrier
06/22/2005CN1629194A Super antigen fusion protein for cancer therapy and its producing method
06/22/2005CN1629190A A protein, gene and pharmaceutical use thereof
06/22/2005CN1629189A Specific antigen of Japanese blood fluke and its use
06/22/2005CN1629188A Specific antigen of Japanese blood fluke and its use
06/22/2005CN1629185A Fusion proteins of mycobacterium tuberculosis antigens and their uses
06/22/2005CN1207390C Process for efficiently expressing high-temp element S oxido-reductase gene
06/22/2005CN1207389C Genetically engineered body of somatostatin gene vaccine (DNA vaccine)
06/22/2005CN1207388C Glyphosate degrading enzyme gene and carrier containing said gene
06/22/2005CN1207387C Polypeptides and genes encoding same
06/22/2005CN1207386C Method of clone gene and its application
06/22/2005CN1207307C Recombination human cytomegalovirus fusion protein and its preparing method, application
06/22/2005CN1207305C Preparing process and application of recombinant human interleukin-11
06/22/2005CN1207302C Method and compounds for curing diseases caused by mutations
06/22/2005CA2487107A1 Novel targets for obesity from skeletal muscle
06/22/2005CA2487098A1 Novel targets for obesity from fat tissue
06/21/2005US6909031 Expression vector coding protein for use in the treatment of diabetes
06/21/2005US6909030 PTTG knockout rodent as a model to study mechanisms for various physiological phenomena, including diabetes
06/21/2005US6908992 Isolated from methylomonas encoding 2-keto-3-deoxy-6-phosphogluconate/fructose bisphosphate aldolase; pyrophosphate dependent phosphofructokinases
06/21/2005US6908991 Mutants; detergents; active materials; oxidation resistance
06/21/2005US6908990 Insulin promoter factor, and uses related thereto
06/21/2005US6908988 Animal models; medical diagnosis; antitumor agents
06/21/2005US6908987 Comprises nucleotide sequences coding peroxisome proliferator activator receptor protein (PCG) for modulating thermogenesis in adipocytes and treating obesity
06/21/2005US6908765 Polypeptide—human SR splicing factor 52 and a polynucleotide encoding the same
06/21/2005US6908762 Method of preparing a eukaryotic viral vector
06/21/2005US6908759 Method of manufacturing kit for isolation nucleic acids or biological materials
06/21/2005US6908758 Human kinase proteins and polynucleotides encoding the same
06/21/2005US6908751 Generation preferential expression vectors; obtain nucleotide sequences, incubate with enzymes, split expression vectors, seal split terminals of expression vectors, recover expresssion vectors
06/21/2005US6908750 Gene encoding HM1.24 antigen protein and promoter thereof
06/21/2005US6908743 Isolated human inositol polyphosphate 5-phosphatase
06/21/2005US6908735 Polynucleotide quantitation method
06/21/2005US6908619 Isolated nucleic acid molecule consisting of sequence encoding immunogenic polypeptide having at least 90% sequence identity to specified contiguous amino acid sequence
06/21/2005US6908618 Production of novel bovine respiratory syncytial viruses from cDNAs
06/21/2005US6908616 Composition suitable for immunizing crustaceans by injection against White Spot Syndrome Virus, WSSV, comprising isolated protein consisting of specified amino acid sequence, which delays mortality against WSSV infectivity in crustaceans
06/21/2005US6908612 Virus coat protein/receptor chimeras and methods of use
06/21/2005US6907887 Genetically engineered plants having reduced nitrosonornicotine, N'-nitrosoanatabine, N'- nitrosoanabasine (NAB), 4-(N-nitrosomethylamino)-1-(3-pyridyl)- 1-butanone levels; cured tobacco
06/21/2005CA2343721C Maize promoters
06/21/2005CA2304926C Robo: a family of polypeptides and nucleic acids involved in nerve guidance
06/21/2005CA2182303C Method of preparing a viral vector by homologous intermolecular recombination
06/21/2005CA2145749C Thrombin activatable plasminogen derivatives
06/21/2005CA2145005C Monoclonal antibodies specific for tcf-ii
06/21/2005CA2049679C Hepatitis c assay utilizing recombinant antigens
06/21/2005CA2015677C Pertussis toxin mutants, bordetella strains capable of producing such mutants and their use in the development of antipertussis vaccines
06/19/2005CA2548723A1 Microbially expressed xylanases and their use as feed additives and other uses
06/18/2005CA2450004A1 Complete mitochondrial genome sequences as a diagnostic tool for the health sciences
06/18/2005CA2450000A1 Method of creating plants with reduced level of saturated fatty acid in seed oil
06/16/2005WO2005054844A1 Reaction vessel and reaction device using the same, detection device and reaction vessel producing method
06/16/2005WO2005054511A1 Method of examining chemical using gene-disrupted strain
06/16/2005WO2005054494A2 Sequence-specific inhibition of small rna function
06/16/2005WO2005054492A1 Method for multiple site-directed mutagenesis
06/16/2005WO2005054486A1 Method of preparing gene transfer reagent
06/16/2005WO2005054485A2 Adenovirus-transfected primary cells and methods of pathway mapping